baber/WOPTO huggingface dataset:
Patent JP-H10502872-A (JP)
IPC: B01J8/04
Filed: 1996-04-19
Abstract: A multi-bed, down-flow reactor includes several distributor assemblies, each having a centrally located mixing chamber and an annular collecting and mixing trough surrounding the mixing chamber. The mixing chamber has an inlet at one side thereof, an outlet in its bottom wall, and a quench gas inlet in its top wall above the outlet. A divider wall traverses the annular trough adjacent to the inlet to cause the pool of liquid collected in the trough to flow in a circular pattern around the mixing chamber to the inlet. This ensures that the liquid circulating through the trough is well mixed with the liquid raining down from the catalyst bed. Turbulent and spiraling flow patterns generated within the chamber further mix the liquid and gas and entrain quench gas in the liquid and gas stream.
Patent JP-2000507823-A (JP)
IPC: C12Q1/68
Filed: 1997-03-27
Abstract: The Von Hippel-Lindau (VHL) disease gene and its corresponding cDNA are disclosed. Methods for detecting carriers of the VHL disease gene using probes derived from the VHL disease gene sequence are described. Pharmaceutical compositions and methods of treating diseases related to the VHL gene are also disclosed.
Patent JP-H11505919-A (JP)
Title: 精密角度測定装置
IPC: B25J3/02
Filed: 1996-05-15
Abstract: (57)【要約】
平行四辺形（６２）の枢動可能に接続された交辺（４０、５０）の間の角度を測定するための装置は、基板（８８）に形成される平行で直線的な複数の格子線（８６）から成るパターン（８４）を有する格子（７８）と、読取りヘッド（８０）とを備えている。上記格子は、上記平行四辺形の第１の辺（５０）に関して固定された位置に取り付けられる。上記読取りヘッドは、センサ（９０）を備えており、このセンサは、上記平行四辺形の交辺の間の角度変化に応答して格子線（８６）の変位を感知し目盛の読取り値を発生するように位置決めされている。上記読取りヘッドは、上記第１の辺に平行な上記平行四辺形の第２の辺（５２）に関して固定された位置に取り付けられている。一実施例においては、上記格子は、複数の格子線から成る単一のパターンを有していて、上記平行四辺形の交辺の間の角度変化の絶対値を測定するために使用される。本精密角度測定装置（７２）は、座標測定機械に特に有用であるが、そのような用途に限定されない。
Patent JP-H11508017-A (JP)
IPC: B01J4/00
Filed: 1997-03-21
Abstract: An infusion pump which is operable to pump a fluid through a tube is described. The pump comprises a shuttle having upstream and downstream sides which is operable to cyclically deform and reform the tube, a first valve associated with the upstream side of the shuttle, a second valve associated with the downstream side of the shuttle and a cam having a first face which is operable to actuate the shuttle and a second face which is operable to actuate the first and second valves.
Patent JP-2001516286-A (JP)
Title: 制御システム用の入出力サブシステム
IPC: B23K11/25
Filed: 1999-01-25
Abstract: (57)【要約】
入出力装置のフィールドバス網は、そのデータ構造に関わらず、Ｉ／Ｏインターフェース・モジュールを通して制御システムに結合する。Ｉ／Ｏインターフェース・モジュールは直列通信ポートを通して制御システムに結合する。ローカル入出力装置はローカルＩ／Ｏインターフェースを通してインターフェースＩ／Ｏモジュールに結合し、網化された入出力装置はフィールドバス通信アダプタを通してインターフェースＩ／Ｏモジュールに結合する。フィールドバス・プロトコルの種類毎に異なるアダプタが必要である。インターフェースＩ／Ｏモジュールはマイクロプロセッサ利用の装置を含み、ローカル装置と網化された装置と制御システムの間の種々の相互作用を生成し制御し、またフィールドバスおよびローカルＩ／Ｏデータ（制御システムと授受するローカル入出力データ）の視覚および状態を表示する。
Patent JP-H11508453-A (JP)
Title: Ｉｌ―１６活性を有するプロセスされたポリペプチド、それらの製法、及びそれらの使用
IPC: A61K38/00
Filed: 1997-04-30
Abstract: (57)【要約】
本核酸は、原核又は真核宿主細胞内でインターロイキン−16活性を有するポリペプチドを発現させることができる。本核酸は、アミノ酸配列番号：２をもつポリペプチド又はそのＮ末端において１のアスパラギン酸残基程伸長され又はＣ末端において８以下のアミノ酸程短縮された配列番号：２をコードする。本核酸は、活性IL−16ポリペプチドの製造のために有用である。
Patent JP-2001505674-A (JP)
Title: Ｖｇａと整合性を有するビデオ表示アダプタを用いて効率的なメモリ読み出し動作を行なうための方法及び装置
IPC: G09G5/00
Filed: 1998-03-24
Abstract: (57)【要約】
ビデオRAM又はキャッシュメモリから所望の情報を読み出すよりむしろ可能な限りラッチから所望の情報を提供することによって、VGAと整合性を有するアダプタなど表示アダプタのビデオRAMから情報を読み出す効率の改善を図る。ビデオRAMの所定の記憶場所の内容を変更するコマンドがあればそうしたコマンドを実行する前に、その記憶場所に格納された全ての画素の情報を先ず読み出すことによって、ビジュアル画像の移動やサイズ変更などグラフィカルユーザインタフェースを用いてのルーチン動作を改善することができる。
Patent JP-2001522396-A (JP)
IPC: C11D3/20
Filed: 1998-04-24
Abstract: The present invention relates to a liquid acidic composition suitable for removing limescale-containing stains from a hard-surface having a pH below 5, and comprising from 0.01% to 20% of the total composition of a sulfamic acid, from 0.01% to 45% by weight of the total composition of a second acid, and from 0.001% to 10% by weight of an acid-stable polymer selected from the group consisting of a polycarboxylate polymer, a sulphonated homopolymer of (poly) styrene, or a sulphonated copolymer of styrene with an ethylenically unsaturated comonomer, a vinylpyrrolidone homopolymer or copolymer, a polyalkoxylene glycol, and mixture thereof. These compositions provide improved shine to the surface treated as well as improved skin mildness to the user skin while exhibiting effective limescale removal performance.
Patent MD-20010055-A (MD)
Title: Microbial sanogenic preparation for prevention and treatment of intestinal disbacteriosis
Inventor: TIMOŞCO MARIA
IPC: A61K35/74
Filed: 2001-03-06
Abstract: The invention refers to medicine, namely to the microbial preparations and may be used for prevention and treatment of the intestinal disbacteriosis.Summary of the invention consists in that the preparation contains new strains of Bifidobacterium adolescentis-Ba-279; Streptococcus thermophilus-St-53 and Lactobacillus acidophilus-La-135, and one dose of preparation contains Ba-279-(6…7)·1010, St-53-(8…9)·108 and La-135-(7…8)·107 of living cells to 1 g.
Patent MX-155552-A (MX)
Inventor: MALDONADO PAUL
IPC: C07C41/01
Filed: 1980-10-14
Abstract: Ethers of polyols are prepared by reaction of a polyol and an organic chloride in a two phase medium in the presence of a phase transfer catalyst. The ethers of polyols are useful as synthetic lubricants, as lubricant bases, as lubricant additives and as fuel additives.
Patent MX-162074-A (MX)
Inventor: METTE ULRICH
IPC: F16C11/06
Filed: 1984-11-05
Abstract: The subject of the invention is the fastening of a sealing bellows to the joint housing of a ball joint, in which the housing-side rim of the sealing bellows is laid firmly into a ring groove circumscribing the joint housing, designed substantially U-shaped in cross section, the bellows rim having a profiling adapted to the U-shape of the ring above and being pressed into the ring groove by a clamp ring. To increase the sealing effect, it is proposed that the profiled zone of the bellows rim lying opposite the bottom of the ring groove forms, when drawn on by the tension ring, a fold lifting off from the bottom of the groove, arched upward, which stretches under the pressure of the clamp ring to force the bellows rim against the side walls of the groove.
Patent NZ-201780-A (NZ)
Title: Dibenzazepine derivatives and pharmaceutical compositions
Inventor: WALTHER G
IPC: C07D513/04
Filed: 1982-09-01
Abstract: Compounds of the formula   <IMAGE>   wherein R1, R2, R3 and R4 are each hydrogen, halogen, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms; R5 is hydrogen, alkyl of 1 to 6 carbon atoms or alkenyl of 3 to 6 carbon atoms; R6 is alkyl of 1 to 6 carbon atoms, alkenyl of 3 to 6 carbon atoms, phenyl, halo-phenyl, lower alkyl-phenyl, or lower alkoxy-phenyl or   <IMAGE>  R7 and R8 are each hydrogen, halogen, alkyl of 1 to 6 carbon atoms or alkoxy or 1 to 6 carbon atoms; n is an integer from 0 to 4, inclusive; x is -O-, -S-, or -CH2-; and the broken line between the 10 and 13b-positions indicates a single or double bond; and non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as antiallergics and antithrombotics.
Patent NZ-222266-A (NZ)
Title: Signal enhancement in immunoassay by modulation of enzymatic catalysis
Inventor: MIZE P D
IPC: C07F9/12
Filed: 1987-10-22
Abstract: A method for enzyme immunoassay for a ligand suspected to be present in a liquid sample includes signal amplification by use of at least two enzymes and a blocked modulator for one of the enzymes. Ligand present in the liquid binds to an antiligand and an enzyme-labeled tracer. The resulting bound fraction is separated and the enzyme in the tracer removes the blocking group from the blocked modulator. The modulator activates or inhibits a second enzyme which catalyzes the conversion of a substrate to a product. The presence or absence of the ligand in the liquid is indicated by a signal, such as a color change or a rate of color change, associated with the product. The invention includes a new class of enzyme inhibitors and blocked inhibitors and a kit of materials useful for performing the method of the invention.
Patent NZ-224866-A (NZ)
Title: Alarm monitoring system - sensors connected to central station by wire and radio
Inventor: SHEFFER ELIEZER A
IPC: H04Q9/00
Filed: 1988-06-01
Abstract: A supervised, interactive alarm reporting system (1) includes a local terminal comprised of a supervised derived channel communicator (5), and a one-way radio communicator (6) (preferably via the cellular telephone network), which are connected by a control unit (7) which provides for interactive operation of the derived channel unit and the radio transmitter according to alarm conditions which may arise at the premises, and the existing condition of the equipment comprising the local terminal unit. The local terminal unit is capable of communicating with a central monitoring facility, or mobile units (patrol vehicles or service vehicles) associated with the central monitoring facility, for enhanced security of the monitored premises. Also an alarm reporting system for a mobile site including a local terminal which communicates with a monitoring facility (fixed or mobile) via the cellular telephone network.
Patent NZ-226427-A (NZ)
Title: Synergistic antiviral composition
Inventor: UENO RYUZO
IPC: C12Q1/68
Filed: 1988-10-03
Abstract: A pharmaceutical composition for treating a disease caused by virus comprising an antiviral agent having no saccharide residue acylated with S-oxoacid and a glycoside having not less than two monosaccharide residue in which not less than one of the said monosaccharide residues have(has) at least one S-oxoacid group attached to the saccharic carbon atom(s) thereof through a linking group with a low molecular weight, or its pharmaceutically acceptable salt.
Patent NZ-237519-A (NZ)
Title: Ipriflavone in an oily carrier
Inventor: CHIESI PAOLO
IPC: A61K47/44
Filed: 1991-03-20
Abstract: Oral pharmaceutical compositions containing ipriflavone are described that are characterised by the use of oily vehicles that promote absorption of the drug enabling the dosage to be simplified.
Patent NZ-242195-A (NZ)
Title: Enterococcus organisms and their use as probiotics in alleviating irritable bowel syndrome symptoms
Inventor: ALLEN WILLIAM DENNIS
IPC: A61K35/74
Filed: 1992-04-01
Abstract: A novel strain of Enterococcus faecium, deposited as NCIMB 40371, has valuable probiotic properties and is particularly effective in alleviating symptoms of irritable bowel syndrome in human patients. The novel strain can be used in the manufacture of human foodstuffs.
Patent NZ-242647-A (NZ)
Title: Laminate, for computerised automated sign making machine, having backing sheet, clear cover sheet and face sheet releasably adhered to cover sheet: method for making sign
Inventor: BARNETTE CHARLES J
IPC: G09F7/00
Filed: 1992-05-07
Abstract: A laminate for use in computerized automated sign making machines and the method for making the same are disclosed. The laminate is formed by adhesively laminating a clear polyester sheet (12) to any suitable decorative backing sheet (10). The polyester sheet (12) has a release coating on a surface thereof which adhesively receives a decorative face sheet. When introduced to an automated sign making machine (56) a movable knife cuts only through the face sheet (52) allowing selected portions of the face sheet to be removed to provide a sign of two decorative features, one defined by the face sheet, and the other by the backing sheet. <IMAGE>
Patent NZ-254864-A (NZ)
Title: N-(carboxyalkyl)-n'-(4-aminophenyl)urea derivatives, the corresponding 4-aminophenylacetamide and -carbamic acid ester analogues and pharmaceutical compositions thereof
Inventor: BURKE PHILIP JOHN
IPC: A61P35/00
Filed: 1993-07-23
Abstract: Prodrugs, of generic formula I, are disclosed for use in antibody directed enzyme prodrug therapy (ADEPT). The prodrugs are substrates for carboxypeptidase G2 (CPG2) and yield more active cytotoxic drugs than known products of CPG2 catalysed reactions.
Patent NZ-271765-A (NZ)
Title: Bridged [1,3]indolo macrocyclic lactam compounds and pharmaceutical compositions
Inventor: CASTELHANO ARLINDO L
IPC: C07D487/04
Filed: 1994-07-27
Abstract: Compounds of formula (I), wherein the dashed lines denote optional double bonds; and when n is 1, 2 or 3; m is 3 or 4; A is -CH2-; R<1> is a) -CH2-R<4> where R<4> is mercapto, acetylthio, carboxy, hydroxyaminocarbonyl, N-hydroxyformamidomethyl, alkoxycarbonyl, aryloxycarbonyl, aralcoxycarbonyl, benzyloxyaminocarbonyl, or (i), where R<6> is optionally substituted aryl, wherein the aryl group is quinol-2-yl, naphth-1-yl, naphth-2-yl, pyridyl or phenyl; b) -CH(R<7>)-R<8> where R<7> is alkyl, hydroxy, amino, aminomethyl, alkylsulphonylamidomethyl, aralkylsulphonylamidomethyl, alkoxycarbonyl, alkoxycarbonylaminomethyl, alkylaminocarbonylamidomethyl, benzoxazoleaminomethyl, aminocarbonyl, or carboxy; and R<8> is carboxy, hydroxyaminocarbonyl, alkoxycarbonyl or aralkoxycarbonyl; c) -NH-CH(R<9>) -R<10> where R<9> is hydrogen, alkyl or aralkyl, and R<10> is carboxy, alkoxycarbonyl, aralkoxycarbonyl, phosphonyl or dialkylphosphonyl; R<2> is alkyl, cycloalkyl, cycloalkylalkyl or aralkyl; and R<3> is hydrogen, halo, alkyl or alkoxy; or when n is 2 or 3; m is 3 or 4; A is -N(R<11>)-, where R<11> is hydrogen or alkyl; and R<1>, R<2> and R<3> are as defined above; or when n is 0; m is 4, 5 or 6; A is -CH(R<12>)-, where R<12> is carboxy, alkoxycarbonyl or optionally substituted carbamoyl; and R<1>, R<2> and R<3> are as defined above; as single stereoisomers or mixtures thereof; or pharmaceutically acceptable salts thereof; are useful in inhibiting matrix metalloprotease activity in mammals.
Patent NZ-296487-A (NZ)
Title: Baking foodstuffs by determining state of a substance from interdependent colour property by forming image and projecting it into colour space and comparing with reference
Inventor: WESTCOTT CHARLES TASMAN
IPC: G06T7/00
Filed: 1995-12-01
Abstract: he present invention is directed towards a method of baking foodstuffs by determining the state of a substance (2) having a color property dependent on the state of the substance.  The method includes the following steps: forming a pixel image of the substance (3) using a camera (3); projecting the pixel image into a three-dimensional color space using a neural network (7); and comparing the projection (37) with a projection of a second position of the substance (2) to determine the state of the substance (2) using a second neural network (9).
Patent NZ-329814-A (NZ)
Title: Shoe press belt including two resin layers, the hardness of at least one resin layer decreasing from the middle to the side edge portions
Inventor: ISHINO ATSUSHI
IPC: D21F3/00
Filed: 1998-02-20
Abstract: A shoe press belt has both sides coated with a resin layer and one or both layers with side edge portions softer than the middle portion of the resin layer. The hardness of the side edge portions may first decrease stepwise laterally outwardly from the middle portion to a section which overlies the edge of the shoe, and then increase stepwise laterally outwardly to the edge of the belt. A first stepwise reduction in hardness may begin laterally inward of the edge of the wet paper sheet and extend laterally outwardly to the edge of the wet paper sheet, where a second stepwise reduction begins that extends laterally outwardly beyond the edge of the shoe. Laterally outwardly of the second reduction, a stepwise increase in hardness extends to the edge of the belt. Alternatively, each side edge portion may be of a single hardness, less than the hardness of the middle portion, and each side edge portion overlies one of the side edges of the shoe. <IMAGE>
Patent NZ-331102-A (NZ)
Title: Cellular telephone system, with additional communication path independent of cell system
Inventor: GOETZ IAN
IPC: H04M1/725
Filed: 1997-02-27
Abstract: A cellular telephone 1 has a connector 7 for connecting it to an interface unit 11.  The interface unit 11 can exchange speech and data signals with the telephone 1, as well as providing power.  When the telephone is connected to the interface unit, its antenna is effectively disabled.  The interface unit provides a link between the telephone and a base transceiver site (BTS) via a communication path other than the cellular telephone system's conventional cell arrangement.  The communication path can include telephone or ISDN connections, leased lines, microwave links or coaxial cable.  Where telephone, ISDN or leased lined are used, baseband speech and data signals pass between the telephone and interface unit, and a modem 14 is used to transmit and receive these signals over the communication path.  If a microwave link or coaxial cable is used, RF speech and data signals may be passed between the telephone and the interface unit.  A single interface unit may be used to provide connections for several telephones.
Patent NZ-332057-A (NZ)
Title: Substituted [2-(1-piperazinyl)ethoxy]methyl compounds
Inventor: DUCHENE GUY
IPC: C07D295/16
Filed: 1997-03-28
Abstract: These substituted [2-(1-piperazinyl)ethoxy]methyl compounds are of formula (I): wherein R1 is a -CONH2, -CN, -COOH, -COOM or -COOR3 group, where M is an alkali metal, R3 is a C1-4 alkyl radical; and R2 is a hydrogen atom or a -COR4 or -R5 group where R4 is selected from -OR6 or -R7 groups, wherein R5 is an allyl or alkylaryl radical, R6 is a straight or branched C1-4 alkyl radical, a haloalkyl radical, alkylaryl, alkylnitroaryl or alkylhaloaryl, and R7 is haloalkyl. A method for preparing the compounds, as well as the use thereof for preparing compounds that are themselves valuable intermediates for the preparation of 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid or 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid and/or pharmaceutically acceptable salts thereof, are disclosed.
Patent NZ-335251-A (NZ)
Title: Substituted phenyl or cyclohexenyl derivatives used as an intermediate to prepare substituted carbazole or tetrahydrocarbazole derivatives
Inventor: ANDERSON BENJAMIN ALAN
IPC: C07D209/88
Filed: 1999-04-16
Abstract: The cyclohexenyl or phenyl derivative has the formula (III) wherein:  PG is an acid protecting group; R21 is a non-interfering substituent; R12 is H or CH2R4 where R4 is H, alkyl, cycloalkyl, pyridyl, phenyl or phenyl substituted with from 1 to 5 substituents selected from alkyl, halo, -CF3, -OCF3, alkoxy, -CN, alkylthio, phenylalkyl, alkylphenyl, phenyl, phenoxy, optionally substituted tetrazole, naphthyl or OR9; R9 and R10 are independently hydrogen, -CF3, phenyl, alkyl, alkylphenyl, or phenylalkyl; R3(a) is H, -O-alkyl, halo, alkyl, optionally substituted phenyl, alkylphenyl, -CH2OSi-alkyl, furyl, thiophenyl, hydroxyalkyl, alkoxyalkyl, alkoxyalkenyl or -(CH2)nR8; R8 is H, NR9R10, -CN or phenyl; n is 1 to 8; Z is cyclohexenyl or phenyl; and X is halo.  Also disclosed is the phenyl derivative of the formula (XVIII) wherein: PG, R21 and R3(a) are as defined above.  A non-interfering substituent refers to radicals suitable for substitution at positions 1, 2, 3, 7 and/or 8 of the ring such as H, alkyl or phenyl.  The compounds of formula III and XVIII are intermediates used in the preparation of certain substituted carbazole or tetrahydrocarbazole derivatives.
Patent NZ-336538-A (NZ)
Title: N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
Inventor: MEERS PAUL R
IPC: A61K9/127
Filed: 1997-10-15
Abstract: A pharmaceutical composition comprising a liposome having a lipid component which comprises: (i)  an N-acyl phosphatidylethanolamine having the formula: CH2-O-R1 ]CH-O-R2 ]CH2-O-P(O)2-O-CH2CH2NH-R3 ; and, (ii)  an additional lipid wherein: each of R1, R2 and R3 is independently a group having the formula: C(O)(CH2)n1(CH=CH)n2(CH2)n3(CH=CH)n4(CH2)n5(CH=CH)n6(CH2)n7(CH=CH)n8(CH2)n9CH3; n1 is zero or an integer equal to from 1 to 22; n3 is zero or an integer equal to from 1 to 19; n5 is zero or an integer equal to from 1 to 16; n7 is zero or an integer equal to from 1 to 13; n9 is zero or an integer equal to from 1 to 10; for each of R1 and R2 independently the sum of n1 + 2n2 + n3 + 2n4 + n5 + 2n6 + n7 + 2n8 + n9 is an integer equal to from 12 to 22; for R3 the sum of n1 + 2n2 + n3 + 2n4 + n5 + 2n6 + n7 + 2n8 + n9 is an integer equal to from 2 to 22; each of n2, n4, n6 and n8 is independently equal to 0 or 1; at least one of n2, n4, n6 and n8 is equal to 1; the lipid component comprises a destabilization-effective amount of the N-acyl phosphatidylethanolamine of at least about 25 mole%; and, the liposome is a multilamellar or is a large unilamellar liposome. The use of the composition in the manufacture of a medicament for localised delivery of a bioactive agent to a target cell is also provided.
Patent NZ-336692-A (NZ)
Title: Edge restraint apparatus having variable length sections
Inventor: JONES STEPHEN
IPC: A01G9/28
Filed: 1998-01-08
Abstract: An edge restraint apparatus for restraining a hard structure includes a substantially upright section (10) having a height and a base section (12) extending from a lower end of upright section (10) on at least one lateral side thereof.  The base section (12) is essentially perpendicular to upright section (10) and has a width.  At least one of the height of upright section (10) and the width of base section (12) is variable.  Upright section (10) and/or base section (12) may be provided with longitudinal weakened portions such as indentations (16A - 16D), score lines (14A, 14B), or different material properties, in order to allow an unwanted portion of the section to be severed and removed.  Extension sections may be provided which are engageable with the upright section and/or the base section.
Patent NZ-502713-A (NZ)
Title: Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization
Inventor: PONCE DE LEON F ABEL
IPC: A01K67/027
Filed: 1998-08-04
Abstract: A  culture system for producing Primordial Germ  Cells (PGCs)  or Embryonic Germ (EG) cells by culturing  PGCs  for long  periods  in tissue culture is provided.  This  culture system  uses  LIF, bFGF, IGF and SCF. The PGCs are  cultured until the culture has a compact, multilayer appearance,  and then  the  EG  cells contained therein are identified.   The resultant  EG  cells  are  useful  for  the  production   of transgenic and chimeric avians, in particular, chickens  and turkeys, and also for cloning purposes.
Patent NZ-503217-A (NZ)
Title: A non-swabable medicament for treatment of muscle soreness which excludes caffeine
Inventor: HOOPER OSWALD EDMOND
IPC: A61K33/18
Filed: 2000-03-02
Abstract: A non swab-able medicament suitable for racehorses for avoiding or treating muscle soreness and/or muscle tying up symptoms comprising potassium iodide 2 g/100 ml and ammonium chloride 2 g/100 ml in a suitable liquid carrier.
Patent NZ-507935-A (NZ)
Title: Use of rev-erb family of receptors in screening
Inventor: RASPE ERIC
IPC: G01N33/68
Filed: 1999-06-21
Abstract: A method of using Rev-erb and/or the response element for the identification of substances that modulate the expression of genes which are regulated by gene promoters containing Rev-erb response elements. Such genes may be involved in lipid metabolism.
Patent NZ-510296-A (NZ)
Title: Gutter system, with rear wall of gutter higher than front wall, and screen over front to rear wall bracket
Inventor: OTTO ANTHONY CHARLES
IPC: E04D13/064
Filed: 2001-03-01
Abstract: A gutter system for use on a building, the gutter system includes (i) a gutter having an open top (101), a front wall (102), a base continuous with the front wall and a rear wall continuous with the base, wherein the rear wall is higher than the front wall; (ii) an internal bracing bracket (108) extending between the front wall and the rear wall; and (iii) a screen (126) located above the internal bracing bracket and supported by the internal bracing bracket, which screen extends substantially over the open top of the gutter, whereby the base wall being higher than the front wall enables the screen to adopt a debris shedding profile.